Similarly, boosting immunity by CSF-2 can be successfully replicated in some neoplastic diseases, as an immune adjuvant for promoting antitumor immunity (Oh et al., 2017; Yan et al., 2017). This evidence concerns the gene CSF2 and neoplasm.